Advertisement
Advertisement
YI
111, Inc. - ADR
2.90
USDSponsored
-0.08
-2.68%
Nov 06, 15:58 UTC -5
Closed
After-Market
2.92
+0.02
+0.86%
111, Inc. - ADR (YI) Earnings
YI Earnings Reports
Positive Surprise Ratio
No Data Available for YI
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
111, Inc. - ADR earnings per share and revenue
On Sep 15, 2026, YI reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nyxoah SA Ordinary Shares
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.30
Actual
-$0.17
Surprise
+42.29%
10x Genomics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.15
Surprise
+43.35%
Doximity, Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$0.35
Actual
$0.36
Surprise
+0.56%
iRhythm Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.06
Actual
$0.82
Surprise
+1,214.10%
Privia Health Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.10
Surprise
+3.73%
Schrodinger, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.70
Actual
-$0.50
Surprise
+29.57%
Enovis Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.78
Actual
$0.88
Surprise
+12.07%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Health Catalyst, Inc Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.03
Surprise
+38.14%
FAQ
What were 111, Inc. - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, 111, Inc. - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to 111, Inc. - ADR's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is 111, Inc. - ADR expected to report next?
The next earning report is scheduled for --.
What are the forecasts for 111, Inc. - ADR's next earnings report?
Based on --
analysts, 111, Inc. - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.